Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Regeneron Pharmaceuticals (NQ:REGN)

568.91 -41.95 (-6.87%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 29, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,660,428
Open 561.75
Bid (Size) 565.00 (1)
Ask (Size) 572.25 (2)
Prev. Close 610.86
Today's Range 542.44 - 579.98
52wk Range 525.99 - 1,211.20
Shares Outstanding 91,779,465
Dividend Yield 0.15%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Discover which S&P500 stocks are making waves on Tuesday.
Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Tuesday as we examine the latest happenings in today's session. 
Via Chartmill
Regeneron Pharma Margins Tighten As Competition Grows, Stock Slides
Regeneron boosts antibody profits with higher Dupixent sales and expands biologics production via FUJIFILM Diosynth partnership. 
Via Benzinga

Performance

YTD
-20.5%
-20.5%
1 Month
-10.3%
-10.3%
3 Month
-17.1%
-17.1%
6 Month
-38.7%
-38.7%
1 Year
-36.3%
-36.3%

More News

Read More
Why Regeneron (REGN) Stock Is Falling Today
Via StockStory
Exploring the top movers within the S&P500 index during today's session.
Via Chartmill
Earnings Scheduled For April 29, 2025
Via Benzinga
Stocks Surge And Bond Yields Fall For 6th Day, Oil Prices Drop To $60: What's Driving Markets Tuesday?
Via Benzinga
Topics Bonds
Exposures Debt Markets
Which S&P500 stocks are gapping on Tuesday?
Via Chartmill
Tuesday's pre-market session: top gainers and losers in the S&P500 index
Via Chartmill
Regeneron Crashes 10% After Eylea Miss Drags Its Earnings Report
Via Investor's Business Daily
Topics Earnings Government
Exposures Financial Political Product Safety
NXP Semiconductors, Brinker International, Ultra Clean, Sanmina And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga
Regeneron (NASDAQ:REGN) Misses Q1 Sales Targets
Via StockStory
Regeneron Reports First Quarter 2025 Financial and Operating Results
From Regeneron Pharmaceuticals, Inc.
Via GlobeNewswire
Large Cap Biopharmaceutical Update: Mixed Performance As Tariffs Loom
Via Talk Markets
Topics ETFs Stocks / Equities
Insights into Regeneron Pharmaceuticals's Upcoming Earnings
Via Benzinga
Why REGENERON PHARMACEUTICALS (NASDAQ:REGN) Deserves Consideration as a Quality Investment.
Via Chartmill
Lynozyfic™ (linvoseltamab) Approved in the European Union for the Treatment of Relapsed/Refractory Multiple Myeloma
From Regeneron Pharmaceuticals, Inc.
Via GlobeNewswire
EYLEA HD® (aflibercept) Injection 8 mg Presentations at ARVO Reinforce Continued Safety and Efficacy and Highlight Early Real-World Outcomes for Patients with Serious Retinal Disease
From Regeneron Pharmaceuticals, Inc.
Via GlobeNewswire
Regeneron (REGN) Reports Earnings Tomorrow: What To Expect
Via StockStory
Topics World Trade
Exposures Tariff
Market Sell-Off: 2 Stocks Down 17% and 36% This Year to Buy and Hold
Via The Motley Fool
Exposures COVID-19
Regeneron Expands US Manufacturing With $3 Billion Fujifilm Deal
Via Benzinga
Regeneron Inks Deal With Fujifilm Diosynth Biotechnologies To Increase Manufacturing In US: Retail’s Optimistic
Via Stocktwits
Topics Economy Stocks
Exposures Economy US Equities
Regeneron Announces New Investment in Manufacturing of its Industry-Leading Biologic Medicines
From Regeneron Pharmaceuticals, Inc.
Via GlobeNewswire
Regeneron Announces Investor Conference Presentations
From Regeneron Pharmaceuticals, Inc.
Via GlobeNewswire
Discover which S&P500 stocks are making waves on Monday.
Via Chartmill
Regeneron Provides Update on EYLEA HD® (aflibercept) Injection 8 mg Supplemental Biologics License Application
From Regeneron Pharmaceuticals, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Regeneron Pharmaceuticals publicly traded?
Yes, Regeneron Pharmaceuticals is publicly traded.
What exchange does Regeneron Pharmaceuticals trade on?
Regeneron Pharmaceuticals trades on the Nasdaq Stock Market
What is the ticker symbol for Regeneron Pharmaceuticals?
The ticker symbol for Regeneron Pharmaceuticals is REGN on the Nasdaq Stock Market
What is the current price of Regeneron Pharmaceuticals?
The current price of Regeneron Pharmaceuticals is 568.91
When was Regeneron Pharmaceuticals last traded?
The last trade of Regeneron Pharmaceuticals was at 04/29/25 04:00 PM ET
What is the market capitalization of Regeneron Pharmaceuticals?
The market capitalization of Regeneron Pharmaceuticals is 52.21B
How many shares of Regeneron Pharmaceuticals are outstanding?
Regeneron Pharmaceuticals has 52B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.